[Medication, steel or radiation? The appropriate strategy to treat facial neuralgia].
Berthele
A
A
Neurologische Klinik und Poliklinik der TU München, Klinikum rechts der Isar.
Tölle
T R
TR
D000588:Amines / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002220:Carbamazepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D019299:Decompression, Surgical; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005156:Facial Neuralgia / Q000209:etiology / Q000628:therapy*; D000077206:Gabapentin; D020435:Glossopharyngeal Nerve Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009408:Nerve Compression Syndromes / Q000175:diagnosis / Q000628:therapy; D010043:Outcome and Process Assessment, Health Care; D000078330:Oxcarbazepine; D016634:Radiosurgery; D014277:Trigeminal Neuralgia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000078330:Oxcarbazepine